1-1 of 1
Yanlei Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study

Available to Purchase
Guoqing Wei, Yanlei Zhang, Houli Zhao, Yiyun Wang, Yandan Liu, Bin Liang, Xiujian Wang, Huijun Xu, Jiazhen Cui, Wenjun Wu, Kui Zhao, Arnon Nagler, Alex H. Chang, Yongxian Hu, He Huang
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (9): 1061–1070.
https://doi.org/10.1158/2326-6066.CIR-20-0675
Published: 01 September 2021
View articletitled, CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study
Open the PDF for CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study in another window
Includes: Supplementary data